Famenka Andrei
State Service of Legal Medicine, Dolgobrodskaya Street, 6-2-23, Minsk, Belarus.
Sci Eng Ethics. 2016 Dec;22(6):1689-1706. doi: 10.1007/s11948-015-9723-4. Epub 2015 Nov 9.
This paper examines the ability of countries in Central and Eastern Europe (CEE) to ensure appropriate protection of research participants in the field of increasingly globalizing biomedical research. By applying an analytical framework for identifying gaps in policies and programs for human subjects protection to four countries of CEE-Belarus, Latvia, Lithuania, and Poland, substantial gaps in the scope and content of relevant policies and major impediments to program performance have been revealed. In these countries, public policies on the protection of research participants lack consistency and reliable mechanisms for their implementation. Impediments to program performance most often relate to inadequacies in the national research ethics systems with regard to organizational structure, budgetary support, supervision, and training. The level of research ethics capacity varies from country to country and depends on socio-economic and political factors of post-communist transition. The breadth and depth of the problems identified suggest that the current level of protection for research participants in CEE might be inadequate to the challenges posed by the globalization of biomedical research. In CEE countries, there is a need for strengthening research ethics capacity through modification of relevant policies and improvement of program management. The differences among the countries call for further research on identifying the best approaches for filling the gaps in the policies and programs aimed at ensuring effective protection of research participants.
本文探讨了中东欧国家在日益全球化的生物医学研究领域确保适当保护研究参与者的能力。通过将用于识别保护人类受试者的政策和计划中差距的分析框架应用于中东欧的四个国家——白俄罗斯、拉脱维亚、立陶宛和波兰,揭示了相关政策在范围和内容上的重大差距以及计划实施的主要障碍。在这些国家,关于保护研究参与者的公共政策缺乏一致性以及可靠的实施机制。计划实施的障碍最常与国家研究伦理体系在组织结构、预算支持、监督和培训方面的不足有关。研究伦理能力水平因国家而异,并取决于后共产主义转型的社会经济和政治因素。所发现问题的广度和深度表明,中东欧目前对研究参与者的保护水平可能不足以应对生物医学研究全球化带来的挑战。在中东欧国家,需要通过修改相关政策和改进计划管理来加强研究伦理能力。各国之间的差异要求进一步研究,以确定填补旨在确保有效保护研究参与者的政策和计划差距的最佳方法。